ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics
Portfolio Pulse from
ScaleReady, in collaboration with Wilson Wolf Manufacturing and Bio-Techne Corporation, has awarded a $125,000 G-Rex Grant to Seattle Children's Therapeutics.
January 08, 2025 | 12:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bio-Techne Corporation, as part of ScaleReady, has awarded a $125,000 G-Rex Grant to Seattle Children's Therapeutics, potentially enhancing its reputation and partnerships in the biotech sector.
The grant award highlights Bio-Techne's active role in supporting healthcare research, which could positively influence its reputation and partnerships, potentially leading to a positive short-term impact on its stock price.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 80